Zumiez reports solid growth but lowers fiscal fourth-quarter guidance due to weaker holiday sales. However, it stays optimistic about growth in fiscal...

IRBT reports fourth-quarter 2024 preliminary results, wherein its revenues and operating results missed the guidance.

IRBT reports fourth-quarter 2024 preliminary results, wherein its revenues and operating results missed the guidance.

lululemon raises its fourth-quarter fiscal 2024 revenue outlook, suggesting 11-12% growth after stronger-than-expected holiday sales.

lululemon raises its fourth-quarter fiscal 2024 revenue outlook, suggesting 11-12% growth after stronger-than-expected holiday sales.

RRGB has reported preliminary results for the fourth quarter of fiscal 2024. Comparable restaurant revenues are expected to rise 3.4%.

RRGB has reported preliminary results for the fourth quarter of fiscal 2024. Comparable restaurant revenues are expected to rise 3.4%.

PacBio reports dismal preliminary fourth-quarter 2024 results, caused by lower instrument. New launches and clinical focus set the stage for market...

PacBio reports dismal preliminary fourth-quarter 2024 results, caused by lower instrument. New launches and clinical focus set the stage for market...

Eli Lilly slashes the revenue guidance for the fourth quarter and fiscal 2024 but offers a bullish outlook for 2025.